EASL Preview: Dual Versus Quad Combinations
This article was originally published in The Pink Sheet Daily
Executive Summary
Data on oral hepatitis C drugs from Pharmasset, Gilead, Vertex, Bristol-Myers and others will be watched closely at the EASL International Liver Congress.